
UDOH Promotes
HPV Vaccine to Prevent Cervical
Cancer
January 7, 2008
In a single year,
it is estimated that more than 11,000
women in the U.S. will be diagnosed
with cervical cancer. Of those,
nearly 3,670 will die. The good
news is that most cervical cancer
deaths can be prevented.
The Utah Department of Health (UDOH)
is observing National Cervical Cancer
Awareness month this January by
calling on all eligible women and
girls to be vaccinated against cervical
cancer.
More than 99 percent of all cervical
cancers are caused by the Human
Papillomavirus (HPV), the most common
sexually transmitted infection in
the U.S., with approximately 50-80%
of sexually active adults having
been exposed to HPV. “Most
of the time, HPV causes no symptoms
or health problems and will simply
go away by itself,” said Karen
Zempolich, MD. “But for some,
a persistent HPV infection as a
young woman can lead to cervical
cancer, requiring surgery or radiation.”
said Zempolich.
In addition to cervical cancer,
HPV causes precancerous changes
of the cervix that affect more than
500,000 women in the U.S. annually.
While precancerous changes are often
treated effectively with minimally
invasive procedures, repeated treatments
can threaten a woman's fertility
and childbearing options.
A vaccine for HPV was approved by
the Food and Drug Administration
(FDA) in June 2006 and is effective
against four strains of the virus
that cause 90% of genital warts
and 70% of cervical cancers.
“Making the vaccine available
to the public is another step forward
in preventing cervical cancer altogether,”
said Kalynn Filion of the UDOH Cancer
Program. “We hope that women
will consider their health and take
this small step in preventing this
potentially deadly disease.”
Vaccination is another layer of
protection against cervical cancer,
but is not a substitute for routine
screening with Pap tests. That’s
because the vaccine does not protect
against all HPV types that cause
cervical cancer.
The vaccine is licensed for use
among females 9-26 and may be given
at the same time as other vaccines.
The Centers for Disease Control
and Prevention (CDC) routinely recommends
the HPV vaccine for girls 11 and
12 years of age, which is given
in a series of three injections
over a six-month period. The vaccine
is also recommended for girls and
women 13 through 26 years of age
who did not receive it when they
were younger.
The UDOH is able to fund the low-cost
vaccines for women ages 19-26 through
a $1 million donation from Utah
industrialist Jon Huntsman, Sr.
Additionally, qualifying adolescents
and teens may receive the vaccine
through the CDC’s Vaccines
for Children (VFC) Program.
There is a small fee charged to
administer the vaccine. For a list
of locations where the vaccine is
available and other cervical cancer
screen services, call 1-800-717-1811
or for more information visit www.utahcancer.org/prevent
#
# #
|